Armonair Digihaler
Payments companies reported to CMS as associated with Armonair Digihaler. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Armonair Digihaler, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Armonair Digihaler
These are the largest totals companies reported as associated with Armonair Digihaler. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Maeve Oconnor | Charlotte, NC | Allergy & Immunology | $3,495.20 |
| Mario Castro | Kansas City, KS | Pulmonary Disease | $1,938.81 |
| Njira Lugogo | Ann Arbor, MI | Pulmonary Disease | $1,938.81 |
| John Oppenheimer | Cedar Knolls, NJ | Allergy | $1,938.81 |
| Rajan Merchant | Woodland, CA | Allergy & Immunology | $1,938.81 |
| Gregory Bensch | Stockton, CA | $1,938.81 | |
| Jay Portnoy | Kansas City, MO | Pediatric Allergy/Immunology | $1,938.81 |
| Donald Mahler | Lebanon, NH | Pulmonary Disease | $1,659.23 |
| Meilan Han | Ann Arbor, MI | Pulmonary Disease | $1,659.23 |
| Fernando Martinez | Worcester, MA | Pulmonary Disease | $1,659.23 |
Prescribed Armonair Digihaler?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.